Bodrova T A, Kostiushev D S, Antonova E N, Gnatenko D A, Bocharova M O, Lopukhin Iu M, Pal'tsev M A, Suchkov S V
Vestn Ross Akad Med Nauk. 2013(1):58-64. doi: 10.15690/vramn.v68i1.539.
Health service today is on the verge of broad changes. The intensive practical application of the achievements of genomics, proteomics, metabolomics and bioinformatics has significantly deepened and continues to deepen our view of the pathological processes taking place at a level of biostructures. In the nearest future this progress will give medical practitioners the opportunity to focus on a subclinical stage of the disease, i.e. on the earliest stages of the pathological process. This will require the prediction of disease development risks, subclinical diagnostics with the precise staging of the pathological process, and, finally, the application as early as possible of targeted pharmacotherapeutic methods in order to prevent the manifestation of the disease or its progression into more severe stages. All these principles create the framework of a fundamentally new "3P" strategy in medicine: predictive, preventive and personalized medicine.
当今的卫生服务正处于广泛变革的边缘。基因组学、蛋白质组学、代谢组学和生物信息学成果的深入实际应用,显著加深且仍在继续加深我们对生物结构层面发生的病理过程的认识。在不久的将来,这一进展将使医学从业者有机会关注疾病的亚临床阶段,即病理过程的最早阶段。这将需要预测疾病发展风险、进行能精确划分病理过程阶段的亚临床诊断,以及尽早应用靶向药物治疗方法,以预防疾病显现或防止其发展到更严重阶段。所有这些原则构成了医学中一种全新的“3P”战略框架:预测性、预防性和个性化医学。